Clinical Trial Update: N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating N-acetylcysteine for pediatric obsessive-compulsive disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Yale University | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2019-09-06